True North Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
True North Advisors's AMGN Position: Q2 2026 in Review
True North Advisors reduced its Amgen (AMGN) stake by 39% in Q2 2026, selling an estimated $227K and leaving 1,057 shares worth $383K. The position accounts for 0.04% of the portfolio, ranked #209.
True North Advisors first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $605K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- True North Advisors held 1,057 shares of Amgen worth $383K as of Q2 2026.
- True North Advisors sold 663 Amgen shares in Q2 2026, an estimated $227K.
- Amgen made up 0.04% of True North Advisors's portfolio in Q2 2026, its #209 holding.
- True North Advisors first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
- True North Advisors's Amgen position peaked at $605K in Q1 2026.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.